Tag Archives: CART

Bristol Myers, flush with pair of CAR-T approvals, blueprints first cell therapy factory in Europe

Right on the heels of not one, but two CAR-T approvals in the U.S., Bristol Myers Squibb is bolstering its commercial cell therapy ambitions on the other side of the Atlantic. The company on Thursday pegged Leiden, Netherlands, as the home of its first cell therapy factory in Europe and its fifth worldwide. With planning for site design and… Read More »

Calling Gilead’s CAR-T infringement ‘willful,’ judge enhances BMS’ award to $1.2B

In quick succession, Gilead Sciences has not only lost an early attempt to overturn a massive CAR-T patent infringement verdict, but now a judge has also ordered hundreds of millions of enhanced damages for plaintiff Bristol Myers Squibb.   Judge Philip Gutierrez in California expanded the total verdict to $ 1.2 billion from a prior… Read More »